Martin Connolly is a drug discovery biologist currently serving as a Senior Research Investigator in Translational Biology at Isomorphic Labs. With extensive experience in leading biology strategies across multiple therapeutic areas, including inflammation and oncology, Martin has successfully progressed projects from hit finding to preclinical work. Previously, Martin held senior roles at C4X Discovery Ltd, Nuritas, and GSK, focusing on assay development and the identification of genetic targets for precision medicine. Martin earned a Ph.D. in Molecular Medicine from Imperial College London and has a Master's degree from Trinity College, Dublin.
Location
London, United Kingdom